- Home
- LUCY vs EVOK Comparison
LUCY vs EVOK Comparison
Compare LUCY & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCY
- EVOK
- Stock Information
- Founded
- LUCY 2017
- EVOK 2007
- Country
- LUCY United States
- EVOK United States
- Employees
- LUCY N/A
- EVOK N/A
- Industry
- LUCY Ophthalmic Goods
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- LUCY Health Care
- EVOK Health Care
- Exchange
- LUCY Nasdaq
- EVOK Nasdaq
- Market Cap
- LUCY 8.7M
- EVOK 7.6M
- IPO Year
- LUCY 2022
- EVOK 2013
- Fundamental
- Price
- LUCY $1.73
- EVOK $5.15
- Analyst Decision
- LUCY
- EVOK
- Analyst Count
- LUCY 0
- EVOK 0
- Target Price
- LUCY N/A
- EVOK N/A
- AVG Volume (30 Days)
- LUCY 134.5K
- EVOK 26.0K
- Earning Date
- LUCY 11-14-2025
- EVOK 11-07-2025
- Dividend Yield
- LUCY N/A
- EVOK N/A
- EPS Growth
- LUCY N/A
- EVOK N/A
- EPS
- LUCY N/A
- EVOK N/A
- Revenue
- LUCY $1,978,018.00
- EVOK $12,794,859.00
- Revenue This Year
- LUCY $149.32
- EVOK $57.38
- Revenue Next Year
- LUCY $400.00
- EVOK $59.57
- P/E Ratio
- LUCY N/A
- EVOK N/A
- Revenue Growth
- LUCY 29.30
- EVOK 70.02
- 52 Week Low
- LUCY $1.57
- EVOK $1.94
- 52 Week High
- LUCY $8.80
- EVOK $9.88
- Technical
- Relative Strength Index (RSI)
- LUCY 36.17
- EVOK 57.04
- Support Level
- LUCY $1.70
- EVOK $4.53
- Resistance Level
- LUCY $1.91
- EVOK $5.19
- Average True Range (ATR)
- LUCY 0.10
- EVOK 0.28
- MACD
- LUCY -0.01
- EVOK 0.07
- Stochastic Oscillator
- LUCY 8.57
- EVOK 91.26
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.